WilliamEKlunkMD
Geriatrics • Pittsburgh, PACo-director of the Alzheimer Disease Research Center at UPMC; Professor of Psychiatry and Neurology at the University of Pittsburgh
Dr. Klunk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3811 Ohara St
Pittsburgh, PA 15213Phone+1 412-246-6460
Education & Training
UPMC Medical EducationResidency, Psychiatry, 1984 - 1988
Washington University in St. Louis School of MedicineClass of 1984
Certifications & Licensure
PA State Medical License 1985 - 2021- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 57 citationsPrevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.Niklas Mattsson, Colin Groot, Willemijn J. Jansen, Susan M. Landau, Victor L. Villemagne
Alzheimer's & Dementia. 2017-07-01 - 442 citationsPrevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.Rik Ossenkoppele, Willemijn J. Jansen, Gil D. Rabinovici, Dirk L. Knol, Wiesje M. van der Flier
JAMA. 2015-05-19 - 111 citationsPreclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.Sarah M. Mills, J. Mallmann, Anna Santacruz, A. Fuqua, M. Carril
Revue Neurologique. 2013-10-01
Journal Articles
- Genome-Wide Association Study of Brain Amyloid Deposition as Measured by Pittsburgh Compound-B (PiB)-PET ImagingOscar L Lopez, Andrew J Saykin, Howard J Aizenstein, William E Klunk, Beth E Snitz, Nature
Press Mentions
Scientists Validate New Lab Test Platform for Alzheimer’s Blood BiomarkersOctober 10th, 2024
Pitt Scientists Validate New Lab Test Platform for Blood Biomarkers of Alzheimer's DiseaseOctober 9th, 2024- Double Whammy: APP Uppsala Deletion Ups Aβ and Its Aggregation PropensityAugust 24th, 2021
- Join now to see all
Grant Support
- Natural History Of Amyloid Deposition Familial ADNational Institute On Aging2010–2012
- Amyloid Pathology And Cognition In Normal ElderlyNational Institute On Aging2005–2012
- In Vivo PIB PET Amyloid IMAGING: Normals, MCI &DementiaNational Institute On Aging2010–2011
- Amyloid-Lowering Small Molecule Ab-Binding Agents In ADNational Institute On Aging2006–2010
- In Vivopib PET Amyloid IMAGING: Normals, MCI &DementiaNational Institute On Aging2008–2009
- Natural History Of Amyloid Deposition In Familial Alzheimers DiseaseNational Institute On Aging2007–2009
- Cross-Sectional Assessment Of In Vivo Amyloid In MCI And ADNational Institute On Aging2005–2009
- Natural History Of Amyloid Deposition In Familial ADNational Institute On Aging2005–2006
- PET Tracers To Monitor Vaccine And Immune Therapy For ADNational Institute On Aging2001–2005
- PET Imaging Probes For Amyloid In Alzheimers And AgingNational Institute On Aging2001–2005
- Clinical Metabolic Correlation In Dementia By Proton NMRNational Institute Of Mental Health1995–1999
- Chemical And Physical Studies Of Beta Amyloid ProteinNational Institute On Aging1996–1997
- NMR Studies Of Brain Aging In Alzheimer'S DiseaseNational Institute On Aging1990
- Molecular Probes For Alzheimer Beta-Amyloid ProteinNational Institute On Aging1988–1989
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
